InvestorsHub Logo
icon url

frrol

11/21/21 3:14 PM

#336759 RE: MayoMobile #336756

I suspect the company will start exploring hypertension in the clinic once we've got our current pipeline plans further along. It's another huge health indication to address and there's lab research like this to support it, plus what we saw inklings of in our AD 2a.
icon url

Ortiz

11/21/21 4:38 PM

#336760 RE: MayoMobile #336756

“atherosclerosis such as hypertension, hypercholesterolemia, smoking, diabetes mellitus and heart failure are associated with diminished release of nitric oxide (NO) into the arterial wall either because of impaired synthesis or excessive oxidative degradation”

Am to think people are expecting a buyout. BP does not have enough money to make an offer.

Great to see diabetes Mellitus mentioned in the article. Connecting the dots.

$1,000/per share minimum.

IMO
icon url

blue finch

11/22/21 1:56 AM

#336782 RE: MayoMobile #336756

Another interesting find
Thanks for your post
icon url

Steady_T

11/22/21 2:09 AM

#336784 RE: MayoMobile #336756

This is another piece of information that add to the possibility that 2-73 will turn out to be a general tonic for overall health improvement for aging and for those in less than great health.

So, 2-73 may turn out to be both a preventative and a tonic. Demonstrating either one of those things is a long way away but it is tantalizing to contemplate.





icon url

bas2020

11/22/21 11:16 AM

#336842 RE: MayoMobile #336756

Good post, Mayo!